Average Co-Inventor Count = 6.79
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Atyr Pharma, Inc. (12 from 92 patents)
2. Pangu Biopharma Limited (8 from 59 patents)
3. Paneu Biopharma Limited (1 from 1 patent)
12 patents:
1. 11807687 - Therapeutic compositions comprising anti-NRP2 antibodies
2. 11505610 - Compositions and methods comprising anti-NRP2 antibodies
3. 11078299 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
4. 10941214 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
5. 10526419 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
6. 10220080 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
7. 10017582 - Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
8. 9687533 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
9. 9605265 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
10. 8945541 - Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
11. 8753638 - Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities
12. 8404242 - Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities